12
Participants
Start Date
September 30, 2006
Primary Completion Date
October 31, 2009
Study Completion Date
December 31, 2009
HIV DNA Vaccine
0.4 mg of DNA plasmids encoding HIV env A, B, C and Rev B, gag A, B and RT mut formulated in PEI and glucose was applied topically with the DermaPrep procedure six times during cycles of 7 weeks of active HAART. Every immunization cycle was followed by four weeks of therapy interruption.
South Hospital, Stockholm
European Union
OTHER
The Swedish Research Council
OTHER_GOV
Läkare mot AIDS Forskningsfond
UNKNOWN
Swedish Institute for Infectious Disease Control
OTHER